IL162817A0 - Process for the manufacture of organic compounds - Google Patents

Process for the manufacture of organic compounds

Info

Publication number
IL162817A0
IL162817A0 IL16281703A IL16281703A IL162817A0 IL 162817 A0 IL162817 A0 IL 162817A0 IL 16281703 A IL16281703 A IL 16281703A IL 16281703 A IL16281703 A IL 16281703A IL 162817 A0 IL162817 A0 IL 162817A0
Authority
IL
Israel
Prior art keywords
manufacture
organic compounds
compounds
organic
Prior art date
Application number
IL16281703A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL162817A0 publication Critical patent/IL162817A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IL16281703A 2002-01-28 2003-01-27 Process for the manufacture of organic compounds IL162817A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35231602P 2002-01-28 2002-01-28
US38318802P 2002-05-24 2002-05-24
PCT/EP2003/000804 WO2003064382A2 (en) 2002-01-28 2003-01-27 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
IL162817A0 true IL162817A0 (en) 2005-11-20

Family

ID=27669055

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16281703A IL162817A0 (en) 2002-01-28 2003-01-27 Process for the manufacture of organic compounds

Country Status (19)

Country Link
US (3) US6835838B2 (zh)
EP (1) EP1472227B1 (zh)
JP (1) JP2005516064A (zh)
KR (2) KR20040077883A (zh)
CN (2) CN1625550A (zh)
AU (4) AU2003239294B2 (zh)
BR (1) BR0307236A (zh)
CA (1) CA2472340A1 (zh)
CO (1) CO5601045A2 (zh)
EC (1) ECSP045202A (zh)
IL (1) IL162817A0 (zh)
MX (1) MXPA04007308A (zh)
NO (1) NO327363B1 (zh)
NZ (3) NZ534136A (zh)
PL (1) PL371383A1 (zh)
RU (1) RU2360903C2 (zh)
SG (2) SG161742A1 (zh)
WO (1) WO2003064382A2 (zh)
ZA (1) ZA200405239B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366831A1 (en) 2001-07-13 2005-02-07 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
ES2364632T3 (es) * 2001-11-14 2011-09-08 Nissan Chemical Industries, Ltd. Procedimiento de producción de éster de ácido oxoheptenoico ópticamente activo.
WO2003064392A1 (en) * 2002-01-31 2003-08-07 Novartis Ag Process for the manufacture of hmg-coa reductase inhibitors
ATE485277T1 (de) * 2002-09-20 2010-11-15 Nissan Chemical Ind Ltd Verfahren zur herstellung eines 3,5-dihydroxy-6- heptenoats
CN101219992B (zh) 2003-02-12 2011-08-31 日产化学工业株式会社 匹伐他汀钙的晶形
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
TWI328006B (en) 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN1763015B (zh) * 2004-10-22 2011-06-22 四川抗菌素工业研究所有限公司 一种罗舒伐他汀及其药用盐的制备方法及中间体
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
ES2564250T3 (es) * 2006-05-03 2016-03-21 Msn Laboratories Private Limited Nuevo proceso para estatinas y sus sales farmacéuticamente aceptables de las mismas
WO2008044243A2 (en) * 2006-10-09 2008-04-17 Manne Satyanarayana Reddy Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
EP2387561A4 (en) * 2009-01-19 2012-07-25 Msn Lab Ltd IMPROVED PROCESS FOR THE PREPARATION OF HIGH-PURITY (3R, 5S) -7-β-CYCLOPROPYL-4- (4-FLUOROPHENYL) QUINOLIN-3-YL-3,5-DIHYDROXY-6 (E) -HEPTENOIC ACID, INCLUDING ITS PHARMACEUTICALLY ACCEPTABLE SALTS
EP2526099B1 (en) 2010-01-18 2016-03-30 MSN Laboratories Limited Improved process for the preparation of amide intermediates and their use thereof
EP2423195A1 (en) 2010-07-26 2012-02-29 LEK Pharmaceuticals d.d. Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
JP2013536219A (ja) * 2010-08-25 2013-09-19 カディラ・ヘルスケア・リミテッド ピタバスタチンカルシウムおよびその調製方法
US8912333B2 (en) * 2010-11-12 2014-12-16 Hetero Research Foundation Polymorphs of pitavastatin calcium
WO2012140490A2 (en) 2011-04-11 2012-10-18 Aurobindo Pharma Limited Process for preparing quinoline derivative
CN103755568B (zh) * 2013-12-10 2015-10-28 江西科技师范大学 IeodomycinA和B立体选择性合成方法
CN107949556B (zh) * 2015-08-05 2021-12-07 株式会社Api 生产匹伐他汀钙的方法
CN108976168B (zh) * 2017-06-02 2020-09-25 浙江京新药业股份有限公司 一种匹伐他汀半钙盐晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3528186B2 (ja) * 1991-06-24 2004-05-17 日産化学工業株式会社 光学活性キノリンメバロン酸のジアステレオマー塩
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3554036B2 (ja) * 1994-09-06 2004-08-11 宇部興産株式会社 光学活性な7−置換キノリル−3,5−ジヒドロキシ−ヘプト−6−エン酸エステル誘導体の製造方法
ES2364632T3 (es) * 2001-11-14 2011-09-08 Nissan Chemical Industries, Ltd. Procedimiento de producción de éster de ácido oxoheptenoico ópticamente activo.
US8212035B2 (en) * 2007-02-08 2012-07-03 Aurobindo Pharma Ltd. Process for preparation of rosuvastatin calcium field of the invention

Also Published As

Publication number Publication date
CN100378081C (zh) 2008-04-02
CN1660818A (zh) 2005-08-31
NZ554367A (en) 2008-11-28
JP2005516064A (ja) 2005-06-02
WO2003064382A2 (en) 2003-08-07
AU2006225205A1 (en) 2006-10-26
AU2003239294B2 (en) 2006-10-19
US20040249154A1 (en) 2004-12-09
CA2472340A1 (en) 2003-08-07
NO327363B1 (no) 2009-06-15
US20090299065A1 (en) 2009-12-03
CN1625550A (zh) 2005-06-08
PL371383A1 (en) 2005-06-13
CO5601045A2 (es) 2006-01-31
AU2006225205B2 (en) 2009-08-06
KR20040077883A (ko) 2004-09-07
ZA200405239B (en) 2005-07-27
AU2006225206A1 (en) 2006-10-26
US20030208072A1 (en) 2003-11-06
MXPA04007308A (es) 2004-10-29
BR0307236A (pt) 2004-12-07
NZ554366A (en) 2008-11-28
SG161742A1 (en) 2010-06-29
SG157225A1 (en) 2009-12-29
NZ534136A (en) 2007-08-31
ECSP045202A (es) 2004-09-28
US7572917B2 (en) 2009-08-11
RU2004126448A (ru) 2005-06-27
EP1472227B1 (en) 2016-04-27
NO20043586L (no) 2004-10-07
AU2009208129A1 (en) 2009-09-03
AU2006225206B2 (en) 2009-08-06
EP1472227A2 (en) 2004-11-03
WO2003064382A3 (en) 2003-12-11
US6835838B2 (en) 2004-12-28
KR20100091267A (ko) 2010-08-18
RU2360903C2 (ru) 2009-07-10

Similar Documents

Publication Publication Date Title
GB0222056D0 (en) Process for the manufacture of organic compounds
ZA200405239B (en) Process for the manufacture of organic compounds
TWI371438B (en) Process for producing an organic compound
EG24716A (en) Combination of organic compounds
GB0204129D0 (en) Process for the manufacture of organic compounds
TWI370811B (en) Process for the preparation of ring compounds
AU2003301257A1 (en) Catalytic process for the treatment of organic compounds
EP1491560A4 (en) PROCESS FOR PRODUCING HIGH MOLECULAR WEIGHT COMPOUNDS FOR PHOTOSENSITIVE RESIN
GB0212412D0 (en) Combination of organic compounds
GB0316546D0 (en) Process for the manufacture of organic compounds
EG24033A (en) Process for the production of olefins
GB0210234D0 (en) Process for the manufacture of organic compounds
IL158400A0 (en) Process for the production of citalopram
GB0402262D0 (en) Process for the manufacture of organic compounds
TWI319391B (en) Process for the production of 3-methylthiopropanal
GB0216311D0 (en) An improved process for the production of substituted thioxanthones
NO20052392D0 (no) Fremgangsmate for fremstilling av acetylenforbindelser.
EP1683776A4 (en) METHOD FOR PRODUCING A RADIOACTIVE, FLUORMARKED COMPOUND
IL166631A0 (en) Process for the production of bisphenol-a
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
EP1539772A4 (en) PROCESS FOR PREPARING PHOSPHORDIAMIDITE COMPOUNDS
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
AU2003268738A8 (en) Processes for preparation of organic compounds
IL164788A0 (en) Process for the preparation of 3-isochromanone